ECHO Program presents Reliance and RWE/RWD modules

ECHO Program (Knowledge Expansion Program), a partnership between Interfarma’s Board of Regulatory Affairs and Anvisa, have held two workshop sessions to discuss Reliance and Real-World Evidence (RWE) / Real-World Data (RWD). The Reliance module also counted on the support of Fifarma. The meetings took place on August 17th and 31st. The RWE/RWD sessions had the … Continued

Interfarma promotes campaign to increase vaccination coverage in Brazil, beyond COVID19

The Pharmaceutical Industry Research Association – Interfarma, Favelas Center Union – Cufa Brazil and the Brazilian Society of Pharmaceutical Medicine – SBMF launched in March, 2021 a Movement called Esquadrão da Vacina (the Vaccine Squad). It is a campaign to raise awareness about the importance of nationwide vaccination, beyond COVID19, considering the decreasing level of … Continued

Interfarma discusses compulsory licensing of patents

President Jair Bolsonaro sanctioned on September 2nd the Bill 12/2021, that allows the compulsory licensing of patents on vaccines and medicines to face public health emergencies. The Bill 12/2021 amends Law No. 9.279, of May 14th, 1996, which regulates rights and obligations related to industrial property.  However, Bolsonaro vetoed provisions that forced patent owners to share information, data … Continued

Interfarma collaborates with public consultation on optimized analysis procedure by Anvisa

Interfarma contributed to Public Consultation no.1039, conducted by Anvisa for the adoption of an optimized analysis procedure. The Agency’s proposed resolution determines the general criteria for taking advantage of the analysis carried out by an Equivalent Foreign Regulatory Authority. The Brazilian agency has been adopting reliance measures – a practice based on reliable information from … Continued

Interfarma elects president and new members of the Management Committee

On June 10th, 2021, Interfarma elected its president, vice-president and new members the management committee. The mandate of all members will be until the next election of the Board of Directors on March 2022.  Hugo Nisenbom, president of MSD, and Patrick Eckert, president of Roche, were elected as president and vice-president of the Board of Directors. Marc Hasson, president of Boehringer Ingelheim, and Roy Benchimol, … Continued

Treinamento do novo Código de Conduta está disponível

A revisão 2021 do Código de Conduta da Interfarma entra em vigor em janeiro de 2022. Para que todas as associadas tenham tempo para se adequar às novas regras, já está disponível no site da Associação o treinamento do novo Código. O objetivo é apresentar a revisão 2021 e reforçar os compromissos e princípios éticos … Continued

Mesa-redonda do GIPI discute dados de testes clínicos

A diretora de Propriedade Intelectual e Compliance da Interfarma, Ana Carolina Cagnoni, participa nesta quarta-feira, 20 de outubro, das 14h às 16h, de mesa redonda organizado pelo Grupo Interministerial de Propriedade Intelectual (GIPI), do Ministério da Economia, para discutir dados de testes clínicos. Durante o evento, serão apresentados os resultados do estudo “Avaliação dos impactos … Continued